No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
FLR240517C37500
- 1.39
- 0.000.00%
15min DelayTrading May 14 14:45 ET
0.00High0.00Low
0.00Open1.39Pre Close0 Volume645 Open Interest37.50Strike Price0.00Turnover44.60%IV0.36%PremiumMay 17, 2024Expiry Date1.25Intrinsic Value100Multiplier2DDays to Expiry0.14Time Value100Contract SizeAmericanOptions Type0.8562Delta0.1533Gamma27.88Leverage Ratio-0.0665Theta0.0023Rho23.87Eff Leverage0.0075Vega
Intraday
- 5D
- 1D
No Data
News
Express News | NYSE Order Imbalance 94037.0 Shares on Buy Side
Express News | NYSE Order Imbalance 92087.0 Shares on Sell Side
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Wedbush rai
Express News | Fluor Corp : Truist Securities Raises Target Price to $47 From $46
Fluor Is Maintained at Outperform by Baird
Fluor Is Maintained at Outperform by Baird
Express News | Baird Maintains Outperform on Fluor, Raises Price Target to $46
Comments
Insiders selling shares, particularly below current price, may be a negative signal. Despite this, the level of insider ownership indicates alignment with common shareholders. The absence of insider trading in the last quarter and recent transactions make us wary about Fluor.
Fluor's Insiders' Timely Sale May Have Helped Mitigate 12% Dip in Share Price 1
Despite Fluor's lower than average ROE, the company demonstrates strong earnings growth and financial performance, likely due to high earnings retention and efficient management. Industry forecasts indicate that this earnings growth is expected to continue.
1
Pre-Market Stock Movers
Gapping up
$Intel(INTC.US$ popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.
$Fluor(FLR.US$ Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
Gapping up
$Intel(INTC.US$ popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.
$Fluor(FLR.US$ Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
22
1
Gapping up
In reaction to earnings/guidance:
• $Comtech Telecommunications(CMTL.US$ +2.1%, $Micron Technology(MU.US$+1.5%
Other news:
• $Amylyx Pharmaceuticals(AMLX.US$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital(RC.US$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron(APRN.US$ +2.5% (CFO to resign)
• $Fluor(FLR.US$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering(IMRX.US$ +1.6% (re...
In reaction to earnings/guidance:
• $Comtech Telecommunications(CMTL.US$ +2.1%, $Micron Technology(MU.US$+1.5%
Other news:
• $Amylyx Pharmaceuticals(AMLX.US$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital(RC.US$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron(APRN.US$ +2.5% (CFO to resign)
• $Fluor(FLR.US$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering(IMRX.US$ +1.6% (re...
10
Gainers:
• $Canoo(GOEV.US$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics(ALDX.US$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel(WPRT.US$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences(GLSI.US$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
• $Canoo(GOEV.US$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics(ALDX.US$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel(WPRT.US$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences(GLSI.US$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
14
Read more